Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Deborah Ashby

51-100 of 143 results

Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420.

scientific article published on February 2012

Oral steroids for long-term use in cystic fibrosis

scientific article (published 2015-12-09)

Ursodeoxycholic acid for cystic fibrosis-related liver disease

Recommendations for benefit-risk assessment methodologies and visual representations

scientific article

An analysis of papers published in the British and European Journals of Orthodontics.

scientific article published on August 1996

Ursodeoxycholic acid for cystic fibrosis-related liver disease

scientific article

Cardiovascular MRI in clinical trials: expanded applications through novel surrogate endpoints

scientific article

Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology.

scientific article published on 5 July 2014

Oral steroids for long-term use in cystic fibrosis

scientific article (published 2013-06-24)

Survival of very preterm infants admitted to neonatal care in England 2008-2014: time trends and regional variation

scientific article published on 7 September 2017

For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not?

scientific article published on 6 February 2008

DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial

scientific article published in the British Medical Journal

Attenuated Salmonella typhimurium SL3261 as a vaccine vector for recombinant antigen in rabbits.

scientific article published on 23 March 2005

A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessment

scientific article published on 28 January 2015

Republished paper: Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis

scientific article published on December 2010

TOIB Study. Are topical or oral ibuprofen equally effective for the treatment of chronic knee pain presenting in primary care: a randomised controlled trial with patient preference study. [ISRCTN79353052].

scientific article

DELTA guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial

Oral steroids for long-term use in cystic fibrosis

scientific article

Where's the utility in Bayesian data-monitoring of clinical trials?

scientific article

Ursodeoxycholic acid for cystic fibrosis-related liver disease

scientific article (published 2014-12-15)

Thrombosis prevention trial: compliance with warfarin treatment and investigation of a retained effect

scientific article (publication date: 23 June 2003)

Prokinetics prescribing in paediatrics: evidence on cisapride, domperidone, and metoclopramide

scientific article published on April 2015

Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin

scientific article published in July 2007

A first-in-human study of the novel HIV-fusion inhibitor C34-PEG4-Chol

scientific article published on 25 August 2017

Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials

scientific article published on 06 May 2019

Challenges and methodology in the incorporation of biomarkers in cancer clinical trials

scientific article published on 21 December 2016

Weighing benefit–risk of medicines: concepts and approaches

scientific article published on January 1, 2011

Suicidal behaviour and SSRIs: updated meta-analysis

scientific article published on June 2006

Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshop

article by Jonathan A. Cook et al published 1 October 2019 in Health Technology Assessment

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis

scientific article

Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment

scientific article

Using disease registries for pharmacoepidemiological research: a case study of data from a cystic fibrosis registry

scientific article published on September 1, 2003

Literature review of visual representation of the results of benefit-risk assessments of medicinal products

scientific article

High prevalence of SARS-CoV-2 swab positivity and increasing R number in England during October 2020: REACT-1 round 6 interim report

Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey

scientific article published on 12 August 2020

Establishing causality in the assessment of safety of medicines for children

scientific article published on 12 September 2008

The use of routinely collected patient data for research: a critical review

scientific article

Cumulative flying time and risk of venous thromboembolism

scientific article published on 08 October 2011

Levosimendan to prevent acute organ dysfunction in sepsis: the LeoPARDS RCT

scientific article published on 16 November 2018

Meeting report: 1st international functional metagenomics workshop may 7-8, 2012, st. Jacobs, ontario, Canada

scientific article

Changes in Cerebral Function Parameters with Maraviroc Intensified Antiretroviral Therapy in Treatment Naïve HIV-Positive Individuals; A Randomised Controlled Study.

scientific article published on 12 February 2018

External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial

scientific article published in March 2017

Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trial

scientific article published on 19 August 2019

Developing routinely recorded clinical data from electronic patient records as a national resource to improve neonatal health care: the Medicines for Neonates research programme

scientific article published on 24 September 2019

Increasing SARS-CoV-2 antibody prevalence in England at the start of the second wave: REACT-2 Round 4 cross-sectional study in 160,000 adults

scientific article

Dicing with Death: Chance, Risk and Health

scientific article published in July 2004

REACT-1 round 9 interim report: downward trend of SARS-CoV-2 in England in February 2021 but still at high prevalence

scientific article

Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults

SARS-CoV-2 rapid antibody test results and subsequent risk of hospitalisation and death in 361,801 people

scientific article published on 16 August 2023

High and increasing prevalence of SARS-CoV-2 swab positivity in England during end September beginning October 2020: REACT-1 round 5 updated report

scientific article